Naujausios naujienos ir straipsniai apie genetinius tyrimus
June 6, 2026
Researchers have found micro-nano-plastics present in artery-clogging plaque in the neck, raising concerns about the potential impact of plastic pollution on cardiovascular health. The study suggests that exposure to microplastics may contribute to the development of atherosclerosis.
June 6, 2026
Researchers at the Salk Institute have identified estrogen-related receptors as potential therapeutic targets for metabolic and muscular disorders. These findings could lead to new treatments for conditions such as diabetes, obesity, and muscle wasting diseases.
June 6, 2026
Researchers at the Salk Institute have identified estrogen-related receptors as potential targets for treating metabolic and muscular disorders. These receptors play a crucial role in regulating energy metabolism and muscle function.
June 6, 2026
Researchers at the Salk Institute have identified a potential link between estrogen-related receptors and metabolic and muscular disorders. Further study of these receptors may lead to new treatments for conditions such as obesity, diabetes, and muscle wasting diseases.
June 6, 2026
A recent study has evaluated the efficacy of a topical cream in reversing signs of aging. The results suggest that this cream may have therapeutic potential, but further research is needed to confirm its effectiveness.
June 6, 2026
Researchers have conducted a study on a topical cream that claims to exhibit anti-aging properties. Preliminary results indicate that this treatment may be effective in reducing signs of aging.
June 6, 2026
KeAi Communications Co., Ltd.. "Scientists test an anti-aging cream that actually works." ScienceDaily. ScienceDaily, 15 September 2025. <www.sciencedaily.com/releases/2025/09/250914205851.htm>.
June 5, 2026
NYU Langone Health / NYU Grossman School of Medicine. "Gene-based blood test for melanoma may catch early signs of cancer's return." ScienceDaily. ScienceDaily, 16 April 2025. <www.sciencedaily.com...
June 5, 2026
Researchers have developed a gene-based blood test that may be able to detect early signs of melanoma recurrence in patients who have completed treatment. This new diagnostic tool has the potential to improve outcomes for individuals at risk of cancer returning.
